BioMark Diagnostics (TSE:BUX) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
BioMark Diagnostics Inc., a company focused on developing early-stage liquid biopsy technologies for cancer detection, welcomes the experienced Theresa Peterson to their advisory team. Peterson’s extensive background includes senior roles at GE Research, expertise in government affairs and securing significant government funding, as well as championing diversity and inclusion within the tech sector. Her appointment is expected to significantly contribute to BioMark’s expansion both in the US and internationally.
For further insights into TSE:BUX stock, check out TipRanks’ Stock Analysis page.